Comprehensive molecular pharmacodynamic assessment identifies response markers of intermediary metabolism associated with BPM 31510-IV treatment in advanced glioblastoma multiforme patients. Nagpal, S., Sarangarajan, R., Bruce, C., Miller, G. M., Rodrigues, L. O., Shah, P., Searfoss, R., Ofori-Mensa, K., Tolstikov, V., Greenwood, B., Bussberg, V., Kiebish, M. A., Granger, E., Narain, N. R., Recht, L. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.15_suppl.2059

View details for Web of Science ID 000708120601016